Cargando…
Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma
Osteosarcoma is among the most common malignant bone tumors in human skeletal system. The conventional treatment of osteosarcoma mainly consists of combining neoadjuvant chemotherapy with surgical approach. However, it is crucial to design an artificial implant that possesses excellent biomechanical...
Autores principales: | Wu, Wei, Dai, Yong, Liu, Han, Cheng, Ruoyu, Ni, Qing, Ye, Tingjun, Cui, Wenguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116704/ https://www.ncbi.nlm.nih.gov/pubmed/30799654 http://dx.doi.org/10.1080/10717544.2018.1497105 |
Ejemplares similares
-
In Situ Sustained Macrophage-Targeted Nanomicelle–Hydrogel Microspheres for Inhibiting Osteoarthritis
por: Li, XiaoXiao, et al.
Publicado: (2023) -
Injectable In Situ Crosslinking Hydrogel for Autologous Fat Grafting
por: Oskarsdotter, Kristin, et al.
Publicado: (2023) -
In Situ Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy
por: Kim, Jihoon, et al.
Publicado: (2021) -
In Situ Crosslinking Bionanocomposite Hydrogels with Potential for Wound Healing Applications
por: Leone, Federica, et al.
Publicado: (2019) -
Additive Soft Matter Design by UV-Induced Polymer Hydrogel Inter-Crosslinking
por: Neuendorf, Talika A., et al.
Publicado: (2022)